使用Clostridioides difficile测试算法检查核酸放大测试选的治疗患者的潜在报告不足

Alice Y Guh1, Scott Fridkin2,3, Dana Goodenough2,3,4

  • 1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

概括

两个步骤的Clostridioides difficile感染 (CDI) 测试算法可能会报告不足的病例. 诸如高白细胞计数和便频率等因素会影响NAAT+/毒素患者的治疗决定.